33.4 F
Key West
Saturday, October 20, 2018
Home STOCKS Stocks Over $10

Stocks Over $10

Privateer Holdings raises another $58M.

Privateer Holdings is raising another big investment round to fuel rapid growth of its marijuana-related subsidiaries as more governments legalize the use of cannabis. The Seattle-based investment firm has reeled in an additional $58 million —...

MJAC2017 Marijuana Conference

LOS ANGELES' PREMIUM INVESTMENT CANNABIS EVENT The future of the legal cannabis industry is looking bright, with new investment opportunities appearing daily. MJAC2017 is a unique environment that allows industry giants from around the world...

Tequila May Be What Diageo (DEO) $134 Needs.

Thomas Franck, CNBC. Tequila may be what Diageo needs to generate more sales in the United States, an analyst from Jefferies said on Friday.Current U.S. revenue growth for the maker of Smirnoff vodka and Johnnie...

GW Pharmaceuticals to Report Q3.

  GW Pharmaceuticals to Report Q3 Financial Results and Host Conference Call on 7 August, 2017 JUL 24, 2017 LONDON, July 24, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH), ("GW" or "the Company"), a biopharmaceutical company...

Molson Coors (TAP). Marijuana Beer. Less Filing! Better Buzz!

Molson Coors is the latest in a line of beer companies to enter the cannabis market. Constellation Brands , the beer giant behind Corona, paid $191 million for a 9.9% stake in Canopy Growth,...

High Times IPO Valued at $225 Million. Accepting Crypto as Payment (CI).

  https://www.crowdfundinsider.com/2018/08/137362-high-times-gets-crypto-buzz-in-reg-a-crowdfunding-offer-possible-nasdaq-listing/ Is rain headed to this parade? During 2016, Cannabis Cup Events generated approximately 68%, of the total consolidated revenues of the company. High Times was acquired by the THC Group in February 2017. The company...

GW Pharmaceuticals (GWPH) Announces $225M Proposed Public Offering.

LONDON, Dec. 05, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (GWPH) ("GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today...

LATEST NEWS

LATEST NEWS

MUST READ